ESTRO 2025 - Abstract Book

S275

Brachytherapy - Gynaecology

ESTRO 2025

Conclusion: In 83% of procedures evaluated with IDE method action was not required. IDE provided us numerical criteria to assess the need for replanning in the second fraction, thus optimising the resources of a second planning.

Keywords: cervical brachytherapy, dosimetric evaluation

References: Pötter R, Tanderup K, Schmid MP, et al. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study. Lancet Oncol. 2021 Apr;22(4):538-547.

Anderson C, Lowe G, Wills R, et al.Critical structure movement in cervix brachytherapy. Radiother Oncol. 2013 Apr;107(1):39-45.